4Holash J,Maisonpierre PC,Compton D,et al.Vessel cooption,regression,and growth in tumors mediated by angiopoietins and EGF[J].Science,1999,284(5422):1994～1998.
6Fujimoto J,SakaguchiH,AokiI,et al.Clinicanimplications of expression of vascular endothelial growthfactorinmetastaticlesions of ovarian cancers[J].Br J Cancer,2001,85(3):313～316.
8Yamamotos S, Konishi I, Mandai M, et al. Expression of Vascular endothelial growth factor (VEGF) in epithelial ovarian nepolims:Correlation with clinicopathology and patient survvivaal analysis of serum VEGF levels[J]. Br J Cancer,1997,76(9) :1221 ～ 1229.
4Folkman J. What is the evidence that tumors are angiogenesis dependent ? J Natl Cancer Inst, 1990,82: 4 ～ 6.
5Neufeld G,Cohen T,Gitay H,et al. Similarities and differences between the vascular endothelial growth factor (VEGF)splice variants. Cancer Metastasis Rev, 1996,15:153～ 158.
6Yamamoto S,Kanishi I,Mandai M ,et al. Expression of vascular ehdothelial growth factor (VEGF)in epithelial ovarian neoplasms:correlation with clinicopathology and patient survival,and analysis of serum VEGF levels. Br J Cancer, 1997,76 (9): 1221～ 1227.
7Shweiki D,Itin A,Soffer D,et al. Vasculai endothelial growth factor induced by hypoxia may mediate hypoxia-intiated angiogenesis.Nature, 1992,359.. 843～845.
8Jie MU,Yoshiko A ,Tateki T,et al. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothlial growth factor activity. Jpn J Cancer Res,1996,87:963～971.
9Timothy A,Mohanraj D,Sabita R,et al. Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothlial growth factor-toxin conjugate. Int J caancer,1997,73:865～870.
